MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Expiration Compliance
20 questions · exam conditions
0:00
Expiration ComplianceQuestion 1 of 20

Retail pharmacy: A pharmacist considers dispensing manufacturer sample stock near expiration; per FD&C Act/state board rules, which factor must be considered?

Samples can be dispensed past expiration because they are not sold
Samples must meet the same expiration-date compliance and storage requirements as other dispensing stock
Samples may be relabeled with a later date if kept in the sample cabinet
Samples are governed only by manufacturer policy, not state board oversight
← Back to quizzes

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Expiration Compliance

Practice Expiration Compliance in MPJE: Multistate Pharmacy Jurisprudence Examination with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Expiration Compliance, giving you a quick way to practice the rules, question types, and explanations that matter most for MPJE: Multistate Pharmacy Jurisprudence Examination.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

Retail pharmacy: A pharmacist considers dispensing manufacturer sample stock near expiration; per FD&C Act/state board rules, which factor must be considered?

  1. Samples can be dispensed past expiration because they are not sold
  2. Samples must meet the same expiration-date compliance and storage requirements as other dispensing stock (correct answer)
  3. Samples may be relabeled with a later date if kept in the sample cabinet
  4. Samples are governed only by manufacturer policy, not state board oversight
Explanation: This question tests MPJE skills in enforcing expiration and beyond-use date rules within pharmacy practice. Pharmacists must adhere to federal and state regulations concerning expiration dates to ensure patient safety and maintain compliance. In this scenario, the pharmacist's decision to dispense or discard a medication is influenced by guidelines from bodies such as the FDA and USP, ensuring medications remain effective and safe. The correct choice demonstrates understanding of these regulations, showing the pharmacist's commitment to legal and ethical practice. Common errors, such as assuming state guidelines override federal law, lead to non-compliance and potential patient harm. Teaching strategies include reviewing current federal and state laws, understanding USP standards for compounding, and emphasizing the importance of patient safety in every dispensing decision.

Question 2

Retail pharmacy: A recalled lot is not involved, but product expires tomorrow; under FD&C Act/state rules, which factor must be considered?

  1. Dispense today for any days' supply because it is not yet expired
  2. Dispense only if patient agrees to store refrigerated to extend expiration
  3. Ensure the quantity dispensed is reasonably expected to be used before expiration and comply with state policy (correct answer)
  4. Relabel with a later date if the seal is intact and NDC matches
Explanation: This question tests MPJE skills in enforcing expiration and beyond-use date rules within pharmacy practice. Pharmacists must adhere to federal and state regulations concerning expiration dates to ensure patient safety and maintain compliance. In this scenario, the pharmacist's decision to dispense or discard a medication is influenced by guidelines from bodies such as the FDA and USP, ensuring medications remain effective and safe. The correct choice demonstrates understanding of these regulations, showing the pharmacist's commitment to legal and ethical practice. Common errors, such as assuming state guidelines override federal law, lead to non-compliance and potential patient harm. Teaching strategies include reviewing current federal and state laws, understanding USP standards for compounding, and emphasizing the importance of patient safety in every dispensing decision.

Question 3

Retail pharmacy: A prescriber requests "dispense as written" from a specific NDC that is expired; under FD&C Act/state rules, what is required?

  1. Dispense the expired NDC to comply with DAW instructions
  2. Do not dispense expired product; obtain non-expired supply or contact prescriber/patient for an alternative (correct answer)
  3. Dispense expired product if patient signs an informed consent form
  4. Override expiration if the drug is not a narrow therapeutic index medication
Explanation: This question tests MPJE skills in enforcing expiration and beyond-use date rules within pharmacy practice. Pharmacists must adhere to federal and state regulations concerning expiration dates to ensure patient safety and maintain compliance. In this scenario, the pharmacist's decision to dispense or discard a medication is influenced by guidelines from bodies such as the FDA and USP, ensuring medications remain effective and safe. The correct choice demonstrates understanding of these regulations, showing the pharmacist's commitment to legal and ethical practice. Common errors, such as assuming state guidelines override federal law, lead to non-compliance and potential patient harm. Teaching strategies include reviewing current federal and state laws, understanding USP standards for compounding, and emphasizing the importance of patient safety in every dispensing decision.

Question 4

Retail pharmacy: A controlled substance bottle is expired; per DEA recordkeeping and state rules, what is the legal requirement for handling it?

  1. Dispense if within 30 days of expiration and keep a note in the profile
  2. Segregate from active stock and process disposal/return through compliant reverse distribution with required records (correct answer)
  3. Flush down the sink if the drug appears degraded to prevent diversion
  4. Relabel with a new date after counting to verify quantity on hand
Explanation: This question tests MPJE skills in enforcing expiration and beyond-use date rules within pharmacy practice. Pharmacists must adhere to federal and state regulations concerning expiration dates to ensure patient safety and maintain compliance. In this scenario, the pharmacist's decision to dispense or discard a medication is influenced by guidelines from bodies such as the FDA and USP, ensuring medications remain effective and safe. The correct choice demonstrates understanding of these regulations, showing the pharmacist's commitment to legal and ethical practice. Common errors, such as assuming state guidelines override federal law, lead to non-compliance and potential patient harm. Teaching strategies include reviewing current federal and state laws, understanding USP standards for compounding, and emphasizing the importance of patient safety in every dispensing decision.

Question 5

A pharmacist is checking inventory on May 15, 2024, and finds a stock bottle of atorvastatin with an expiration date printed as 'EXP 07/2024'. The pharmacy's policy is to pull medications from stock one month prior to their expiration.

According to federal law, what is the last day this bottle of atorvastatin can be used to dispense a prescription?

  1. June 30, 2024, as per the pharmacy's internal policy for stock rotation.
  2. July 1, 2024, because the medication is considered expired on the first day of the listed month.
  3. July 15, 2024, aligning with the mid-point of the expiration month.
  4. July 31, 2024, as the expiration date includes the entire last day of the specified month. (correct answer)
Explanation: The correct answer is D. Federal law and common practice interpret a manufacturer's expiration date listed as month and year (e.g., 07/2024) to mean the drug is stable and effective through the last day of that month. Therefore, the atorvastatin can be dispensed until the end of the day on July 31, 2024. A is incorrect because internal pharmacy policy is for quality control and does not define the legal expiration date. B and C are incorrect interpretations of how expiration dates are defined.

Question 6

A patient brings a new prescription for amlodipine 5 mg, quantity 90, to the pharmacy on June 10, 2024. The only stock bottle available has an expiration date of October 2024.

What is the most appropriate action for the pharmacist to take in this situation?

  1. Dispense the full 90-day supply, as the medication expires after the supply is completed.
  2. Refuse to fill the prescription and inform the patient that the drug is out of stock.
  3. Dispense a partial supply that will be consumed before October 31, 2024, and arrange for the remainder. (correct answer)
  4. Dispense the full 90-day supply but place a 'use by September 10, 2024' sticker on the vial.
Explanation: The correct answer is C. A pharmacist should not dispense a quantity of medication that will be used after the product's expiration date. A 90-day supply dispensed on June 10 would last until approximately September 8, which is before the October 31 expiration date. However, best practice and many state laws prohibit dispensing a medication that expires before the patient is scheduled to complete the therapy. Dispensing a partial fill and ordering a new bottle is the most professionally responsible action to ensure the patient receives medication that is potent for the entire duration of use. A is incorrect because it is poor professional practice. B is incorrect because the drug is not truly out of stock and this action delays patient care. D is incorrect as the pharmacist should not dispense a full supply that will expire during the treatment course.

Question 7

A hospital pharmacy technician is repackaging bulk metoprolol succinate ER 25 mg tablets into unit-dose blisters on August 15, 2024. The manufacturer's stock bottle has an expiration date of March 2026.

According to USP guidelines for repackaging, what is the maximum allowable beyond-use date for these unit-dose packages?

  1. The original manufacturer's expiration date of March 31, 2026.
  2. Six months from the date of repackaging, which is February 15, 2025.
  3. One year from the date of repackaging, which is August 15, 2025. (correct answer)
  4. Twenty-five percent of the time remaining until the manufacturer's expiration date.
Explanation: The correct answer is C. In the absence of stability data to the contrary, USP standards state that the beyond-use date for non-sterile solid and liquid dosage forms repackaged into unit-dose containers is one year from the date of repackaging or the manufacturer's expiration date, whichever is earlier. In this case, one year from repackaging is August 15, 2025, which is earlier than March 2026. B and D represent older or alternative guidelines but are not the current prevailing USP standard. A is incorrect because the repackaging process itself introduces variables that prevent guaranteeing stability until the original expiration date.

Question 8

An inspector from the State Board of Pharmacy is conducting a routine pharmacy inspection and finds a bottle of hydrochlorothiazide tablets on the active dispensing shelf. The bottle's expiration date is from two months prior.

Under the Federal Food, Drug, and Cosmetic Act, how would this bottle of hydrochlorothiazide be legally classified?

  1. Misbranded, because its label is now false or misleading.
  2. Adulterated, because it is a drug held under insanitary conditions whereby it may have been contaminated.
  3. Adulterated, because its strength, quality, or purity falls below the standard set forth in the official compendium. (correct answer)
  4. Counterfeit, because it can no longer be verified as the authentic product from the manufacturer.
Explanation: The correct answer is C. An expired drug is considered adulterated. The drug's purity, strength, and quality are only assured until the expiration date. After this date, it is presumed to fall below compendial standards, even if its physical appearance is unchanged. While it could also be considered misbranded (A), the primary violation related to its expired status is adulteration. B is a different definition of adulteration that doesn't fit this specific scenario as well. D is incorrect, as the drug is not a counterfeit product.

Question 9

A parent brings in a prescription for their child for amoxicillin oral suspension. The pharmacist reconstitutes the powder with distilled water on July 20. The pharmacy's refrigerator is working properly.

What is the primary factor that determines the beyond-use date for the reconstituted suspension?

  1. USP <795> guidelines for aqueous oral liquids, which dictate a 14-day BUD under refrigeration.
  2. The manufacturer's stability data for the product after reconstitution, found in the package insert. (correct answer)
  3. State pharmacy law, which typically mandates a 10-day expiration for all reconstituted antibiotics.
  4. The expiration date printed on the bottle of dry powder before it was mixed.
Explanation: The correct answer is B. For commercially available products that require reconstitution (like powdered antibiotics), the beyond-use date is determined by the manufacturer's stability studies and is specified in the product's package insert. This is not considered compounding from bulk ingredients, so the default USP <795> BUDs (A) do not apply. While state law (C) could impose a stricter requirement, it is the manufacturer's data that provides the standard BUD (e.g., 10 or 14 days for amoxicillin, depending on storage). The original powder's expiration date (D) applies only to the un-reconstituted product.

Question 10

A community pharmacy provides and maintains an emergency kit for a local long-term care facility (LTCF). The kit contains various medications, including controlled substances.

Regarding the expiration dates of the drugs within this emergency kit, what is the pharmacy's primary responsibility?

  1. To ensure that the kit is returned to the pharmacy for restocking only when the LTCF staff reports an expired drug.
  2. To assign a single expiration date to the entire kit, which is the date of the earliest-expiring drug inside. (correct answer)
  3. To label each drug with a one-year beyond-use date from the time it was placed in the kit.
  4. To ensure the LTCF is responsible for checking all expiration dates and replacing drugs as they see fit.
Explanation: The correct answer is B. For emergency kits supplied to LTCFs, the exterior of the kit must be labeled with the earliest expiration date of any drug contained within. This allows staff to quickly identify when the kit needs to be exchanged or serviced. A is incorrect because the pharmacy must proactively manage the kit, not wait for the LTCF to report an issue. C is incorrect as the drugs retain their original manufacturer's expiration dates. D is incorrect as the supplying pharmacy, not the LTCF, is ultimately responsible for the contents and integrity of the kit.

Question 11

A prescription for cephalexin 500 mg capsules with a quantity of 30 is filled, but the patient never picks it up. The pharmacy's policy is to return unclaimed prescriptions to stock after 14 days. The original stock bottle from which the prescription was filled had lot #ABC and an expiration date of 12/2025. The current stock bottle on the shelf has lot #DEF and an expiration date of 06/2026.

What is the proper procedure for returning the cephalexin capsules to the pharmacy's inventory?

  1. Mix the returned capsules into the current stock bottle (lot #DEF) since the expiration date is later.
  2. Hold the returned capsules separately and dispense them first for the next cephalexin 500 mg prescription. (correct answer)
  3. Dispose of the capsules because once dispensed in a vial, they cannot be returned to inventory.
  4. Assign a new beyond-use date of 14 days from the return-to-stock date.
Explanation: The correct answer is B. Federal law prohibits the commingling of different lots of a drug. Therefore, the returned capsules from lot #ABC cannot be mixed with the stock bottle of lot #DEF. The proper procedure is to keep the returned medication in its vial (or a separate stock container with the correct lot/expiration information) and use it for the next fill. A is incorrect due to the prohibition of mixing lots. C is incorrect because medications that have not left the pharmacy's control and are stored properly can typically be returned to stock. D is incorrect as the medication retains its original manufacturer's expiration date.

Question 12

A pharmacist working in a state with a drug repository (donation) program receives a sealed, unopened, and unexpired box of Janumet from a patient's family. The medication has a manufacturer's expiration date of 8 months from now.

According to common regulations for drug repository programs, what is the most likely requirement for this medication to be accepted and redispensed?

  1. The medication must have at least one year remaining before its expiration date.
  2. The medication must be repackaged and assigned a new 6-month beyond-use date.
  3. The medication must have at least six months remaining before its expiration date. (correct answer)
  4. The medication can be accepted and dispensed up until the last day of its expiration month.
Explanation: The correct answer is C. Most state drug repository/donation programs have specific requirements for donated drugs, including a minimum amount of time remaining until expiration. A common standard is that the drug must have at least six months left on its expiration date to be accepted and redispensed, ensuring the next patient has adequate time to use it. A one-year requirement (A) is less common and overly restrictive. Repackaging and assigning a new BUD (B) is incorrect. Dispensing up to the expiration date (D) does not allow the recipient sufficient time to use the medication and is typically not allowed.

Question 13

A nurse in a clinic opens a new 10-dose multi-dose vial of a vaccine at 9:00 AM on Monday, October 7th. The manufacturer's expiration date on the vial is December 2025. The manufacturer's instructions state that once punctured, the vial must be discarded within 28 days.

What information must the nurse record on the vial to ensure proper expiration compliance?

  1. Only the date it was opened (October 7th).
  2. The calculated 'discard by' date (November 4th). (correct answer)
  3. Both the opening date and discard date with times.
  4. The original manufacturer's expiration date only.
Explanation: The correct answer is B. For multi-dose vials, it is critical to label them with the new beyond-use date (or 'discard by' date) once they are opened. This new date is 28 days from October 7th, which is November 4th. Simply writing the open date (A) is insufficient as it requires every subsequent user to perform a calculation, increasing the risk of error. While including the time (C) is good practice, the most critical element required by organizations like the CDC is the discard date. The original expiration date (D) is no longer the sole determinant of the vial's usability after it has been punctured.

Question 14

A pharmacist compounds a hydrophilic cream containing 2% hydrocortisone powder and 1% ketoconazole powder in a commercial aqueous cream base. The compound is prepared on February 1, 2024. The earliest expiration date of any ingredient is June 2025.

Under USP <795> guidelines, what is the maximum beyond-use date that should be assigned to this water-containing topical preparation?

  1. 14 days, stored at room temperature.
  2. 30 days, stored at room temperature. (correct answer)
  3. 6 months, stored at room temperature.
  4. 1 year, as long as it is refrigerated.
Explanation: The correct answer is B. According to USP Chapter <795>, the default beyond-use date for water-containing topical/dermal and mucosal liquid and semisolid formulations (like this cream) is not later than 30 days. This assumes storage at room temperature. A is the BUD for oral aqueous formulations. C is the BUD for non-aqueous formulations. D is an incorrect time frame and storage condition combination for this type of compound.

Question 15

During a cardiac emergency on a hospital floor, a nurse asks a pharmacist to immediately prepare a dose of IV push epinephrine. The preparation is done at the patient's bedside, outside of a certified sterile compounding area.

According to USP <797> guidelines for immediate-use compounded sterile products, how long after preparation must the administration of this dose begin?

  1. Within 1 hour. (correct answer)
  2. Within 4 hours.
  3. Within 12 hours.
  4. Within 24 hours.
Explanation: The correct answer is A. USP Chapter <797> defines specific conditions for 'immediate-use' compounded sterile products (CSPs) intended for emergency situations. These preparations are made under less-than-ideal aseptic conditions, and their use is therefore strictly limited. Administration must begin within one hour of the start of the preparation, and the CSP must be discarded if administration has not begun within that hour. The other timeframes are incorrect and apply to CSPs prepared in higher-quality environments (e.g., low, medium, or high-risk CSPs).

Question 16

A patient purchases an over-the-counter (OTC) bottle of ibuprofen from the front of a pharmacy and later discovers that the product expired the previous month.

What is the primary legal violation committed by the pharmacy in this situation?

  1. Practicing medicine without a license, as they provided a sub-potent medical product.
  2. Dispensing a prescription drug without a valid prescription.
  3. The sale of an adulterated and/or misbranded drug. (correct answer)
  4. A violation of DEA regulations regarding inventory control.
Explanation: The correct answer is C. The sale of any drug, including OTC products, after its expiration date constitutes the sale of an adulterated drug. It may also be considered misbranded because the labeling, which includes the expiration date, is no longer accurate regarding the product's stability and potency. A is incorrect as this does not constitute practicing medicine. B is incorrect because ibuprofen is an OTC drug. D is incorrect because the DEA regulates controlled substances, not OTC ibuprofen.

Question 17

A pharmacist is loading an automated dispensing cabinet (ADC) on a hospital floor. One of the medications to be loaded, a vial of heparin, has an expiration date of two months from now.

What is the most appropriate action for the pharmacist to take?

  1. Load the medication into the ADC since it has not yet expired.
  2. Load the medication, but place a warning sticker on it for the nursing staff.
  3. Return the heparin to the main pharmacy for more immediate dispensing needs.
  4. Do not load the medication and segregate it with other short-dated inventory. (correct answer)
Explanation: The correct answer is D. Most health systems have policies against loading short-dated medications (e.g., those expiring in less than 3-6 months) into ADCs. This is to prevent the likelihood of an expired drug being stored in and dispensed from a remote location. The proper action is to not load the short-dated medication and to segregate it for proper handling, which may include returning it to the main pharmacy for more rapid dispensing (C) or returning it to the wholesaler if possible. Simply loading it (A) or loading it with a sticker (B) creates an unacceptable risk that it will expire before being used.

Question 18

A central-fill pharmacy is repackaging a large batch of losartan 50 mg tablets into unit-dose containers for distribution to its affiliated retail stores. The repackaging occurs on September 1, 2024. The manufacturer's expiration date on the bulk container is May 31, 2025.

What is the correct beyond-use date to assign to the repackaged unit-dose products?

  1. September 1, 2025, which is one year from the date of repackaging.
  2. May 31, 2025, which is the original manufacturer's expiration date. (correct answer)
  3. March 1, 2025, which is six months from the date of repackaging.
  4. November 1, 2024, which is 25% of the time remaining on the original product.
Explanation: The correct answer is B. The USP guideline for repackaged unit-dose products is to assign a beyond-use date that is the shorter of two options: 1) one year from the date of repackaging, or 2) the manufacturer's original expiration date. In this scenario, one year from repackaging would be September 1, 2025. However, the manufacturer's expiration date is May 31, 2025. Since May 31, 2025, is earlier, it must be used as the BUD. A is incorrect because it exceeds the manufacturer's expiration date. C and D are incorrect calculation methods.

Question 19

A patient with diabetes purchases a new vial of insulin glargine on April 1. The manufacturer's expiration date on the box is June of the following year. The patient begins using the vial on April 5 and stores it at room temperature as permitted by the manufacturer.

The patient asks the pharmacist when they should discard this specific in-use vial. What is the most accurate advice the pharmacist should provide?

  1. Discard the vial on June 30 of the following year, according to the manufacturer's printed expiration date.
  2. Discard the vial 28 days after the purchase date, which is April 29.
  3. Discard the vial 28 days after the first use, which is May 3, or as specified by the manufacturer. (correct answer)
  4. Discard the vial after one year from the date of purchase, as with other prescription medications.
Explanation: The correct answer is C. Many multi-dose injectable products, including most insulins, have a specific in-use stability, which becomes the effective expiration date once the vial is punctured. For insulin glargine and many others, this is typically 28 days after first use when stored at room temperature (unless the manufacturer specifies otherwise). The original manufacturer's expiration date (A) applies only to unopened, properly stored vials. The purchase date (B) is irrelevant; the clock starts with the first puncture. The one-year rule for dispensed drugs (D) does not apply to multi-dose vials with specific in-use stability limitations.

Question 20

A state's pharmacy regulations require that the beyond-use date on a dispensed prescription label shall not exceed the manufacturer's expiration date or 15 months from the date of dispensing, whichever is earlier. Federal guidelines generally follow the USP standard of one year.

A pharmacist in this state dispenses a medication on 04/01/2024 from a stock bottle expiring 12/31/2026. Which beyond-use date should be placed on the label?

  1. 04/01/2025, to comply with the stricter federal/USP guideline. (correct answer)
  2. 07/01/2025, to comply with the more lenient state law of 15 months.
  3. 12/31/2026, to match the manufacturer's expiration date.
  4. A date determined by the pharmacist's professional judgment, as the laws conflict.
Explanation: The correct answer is A. When federal and state laws differ, the pharmacist must follow the stricter of the two. In this case, the federal/USP guideline of one year (04/01/2025) is stricter (i.e., a shorter time frame) than the state law of 15 months (07/01/2025). Therefore, the pharmacist must use the one-year beyond-use date. B is incorrect because it follows the less strict law. C is incorrect because a BUD must be assigned when repackaging from a bulk container. D is incorrect because the conflict is resolved by adhering to the more stringent requirement.